IgA Np is the most commonly observed form of primary GN worldwide. IgA Np is more commonly seen among Asians & Caucasians.
Clinical
presentation and diagnosis of IgA nephropathy (IgA Np)
Abbreviations:
o
IgA Np: IgA nephropathy.
o
LM: Light
microscopy
o
E/M: Electron
microscopy
o
IF: immunofluorescence
o
HT: Hypertension
o
GN: glomerulonephritis
o
GS: Glomerulosclerosis.
o
NS: Nephrotic syndrome,
o
AKI: acute kidney
injury,
o
Im/m: immunosuppressive
therapy
o
IF/TA: Interstitial fibrosis/Tubular atrophy.
o
SCr: serum
creatinine concentration
o
eGFR: estimated
glomerular filtration rate,
o
MCD: minimal
change disease.
IgA Np is the most commonly observed form of
primary GN worldwide. IgA Np
is more commonly seen among Asians & Caucasians.
There’s a 2:1
male-to-female tendency in Caucasians but not present in East Asians, where both sexes
are equally involved. Pathology of IgA
Np is characterized by mesangial prominent, globular
deposits of IgA seen on IF testing.
LM may show diffuse mesangial proliferation
+ matrix expansion with proliferative GN
and segmental GS with IF/TA
and inflammation in advanced disease. E/M usually shows mesangial dense deposits.
The Oxford classification
recognizes the varieties correlated to renal
outcome regardless the clinical presentation
at baseline, proteinuria level, and BP
control. Application of this scoring system in determining therapy requirements for further
evaluation.
Oxford classification of IgA Np
The current
recommendation is that each renal biopsy report should include variable scoring
according to the presence/absence of these 5 variables (MEST-C). Scoring
system is recognized as follows:
1) Mesangial
hypercellularity: mesangial cells counted per mesangial area, & a scoring of 0-3 is given for each glomerulus. Zero =
< 4 mesangial
cells per mesangial area; one = 4-5 cells; 2 = 6-7 cells; &
3 = > 8
mesangial cells are present per mesangial area. Scoring is usually in average,
and hypercellularity scoring is either M0
if the mean score is < 0.5 or M1 if the
mean score is > 0.5.
2) Endocapillary hypercellularity: E1 = hypercellularity inside glomerular
capillary lumen > narrowed lumen, or
absent (E0) = no luminal hypercellularity.
3) Segmental GS: S1
= any part of glomerular tuft showed sclerosis, or absent (S0) = no segmental GS.
4) Tubular
atrophy/interstitial fibrosis
(IF/TA): % of
cortical area with TA or IF is calculated.
Scoring of T0, T1, or T2
is given if the % of affected cortical area is 0-25,
26-50,
or >50 %, resp.
5) Crescents: defined as: cellular and/or
fibrocellular crescents at least one glomerulus = C1, at least 25 % of glomeruli = C2, or absent = C0.
Biopsy of < 8
glomeruli is NOT of prognostic value. A predictive tool combining clinical + histologic (MEST-C) data at Dgx can predict
the risk of kidney function deterioration (= 50 % decline in eGFR
or developed ESKD) within 5-7 ys.
IgA Np manifestations are confined to the kidney.
Mesangial IgA deposits, which is usually clinically silent, may also be observed with cirrhosis, celiac
disease, & HIV infection (clinically
apparent disease may be also seen).
Moreover, IgA Np may be rarely be seen with other forms of Glomerulopathy e.g., MCD & granulomatosis with polyangiitis. Ptns with IgA
Np are mostly presented with either gross hematuria
(single or
recurrent), usually with upper
respiratory tract infection, or microscopic hematuria +/-
mild proteinuria incidentally discovered with routine examination.
Rarely, ptns may develop AKI +/- oliguria,
owing to either crescentic IgA Np
or to gross hematuria leading to tubular obstruction and/or RBCs damage. Dgx of IgA Np
is usually established based on clinical history but can be confirmed via a kidney biopsy. Renal
biopsy is usually resorted to asses suspected IgA
Np only if there’re Sns suggesting
more intense or progressive disease e.g., proteinuria > 500 mg/d, increased SCr,
or HT.
COMMENTS